WOCKHARDT Financial Statement Analysis
|
||
The Revenues of WOCKHARDT have decreased by -17.93% YoY .
The Earnings Per Share (EPS) of WOCKHARDT has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
WOCKHARDT Last 5 Annual Financial Results
[BOM: 532300|NSE : WOCKPHARMA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹2,651 Cr | ₹3,230 Cr | ₹2,708 Cr | ₹2,844 Cr | ₹3,566 Cr |
Expenses | ₹2,550 Cr | ₹2,932 Cr | ₹2,771 Cr | ₹2,746 Cr | ₹3,604 Cr |
Operating Profit (Excl OI) | ₹101 Cr | ₹298 Cr | ₹-63 Cr | ₹98 Cr | ₹-38 Cr |
Other Income | ₹122 Cr | ₹20 Cr | ₹132 Cr | ₹60 Cr | ₹21 Cr |
Interest | ₹302 Cr | ₹299 Cr | ₹249 Cr | ₹276 Cr | ₹265 Cr |
Depreciation | ₹251 Cr | ₹247 Cr | ₹246 Cr | ₹224 Cr | ₹164 Cr |
Profit Before Tax | ₹-624 Cr | ₹-411 Cr | ₹-568 Cr | ₹-342 Cr | ₹-447 Cr |
Profit After Tax | ₹-621 Cr | ₹-279 Cr | ₹-297 Cr | ₹-138 Cr | ₹-312 Cr |
Consolidated Net Profit | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr | ₹-195 Cr |
Earnings Per Share (Rs) | ₹-38.82 | ₹-16.94 | ₹62.36 | ₹-6.25 | ₹-17.58 |
PAT Margin (%) | -14.53 | -5.44 | -6.41 | -4.85 | -8.74 |
ROE(%) | -17.32 | -7.77 | -9.92 | -5.22 | -11.43 |
ROCE(%) | -5.88 | -1.96 | -5.50 | -1.11 | -2.87 |
Total Debt/Equity(x) | 0.57 | 0.49 | 0.70 | 1.22 | 1.28 |
Key Financials |
||
Market Cap | : | ₹ 8,747.6 Cr |
Revenue (TTM) | : | ₹ 2,776.0 Cr |
Net Profit(TTM) | : | ₹ -532.0 Cr |
EPS (TTM) | : | ₹ -34.7 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
WOCKHARDT | -2.4% | 4.2% | 231.5% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
WOCKHARDT Revenues
[BOM: 532300|NSE : WOCKPHARMA]
Y-o-Y | -17.93 % |
5 Yr CAGR | -7.14 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹2,651 Cr | -17.93 | |
Mar2022 | ₹3,230 Cr | 19.28 | |
Mar2021 | ₹2,708 Cr | -4.78 | |
Mar2020 | ₹2,844 Cr | -20.24 | |
Mar2019 | ₹3,566 Cr | - |
WOCKHARDT Operating Profit
[BOM: 532300|NSE : WOCKPHARMA]
Y-o-Y | -66.11 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹101 Cr | -66.11 | |
Mar2022 | ₹298 Cr | Positive | |
Mar2021 | ₹-63 Cr | Negative | |
Mar2020 | ₹98 Cr | Positive | |
Mar2019 | ₹-38 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -58.72 % |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 3.81% | -58.72 | |
Mar2022 | 9.23% | Positive | |
Mar2021 | -2.33% | Negative | |
Mar2020 | 3.44% | Positive | |
Mar2019 | -1.08% | - |
WOCKHARDT Profit After Tax
[BOM: 532300|NSE : WOCKPHARMA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹-559 Cr | Negative | |
Mar2022 | ₹-244 Cr | Negative | |
Mar2021 | ₹686 Cr | Positive | |
Mar2020 | ₹-69 Cr | Negative | |
Mar2019 | ₹-195 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -14.53 % | Negative | |
Mar2022 | -5.44 % | Negative | |
Mar2021 | -6.41 % | Negative | |
Mar2020 | -4.85 % | Negative | |
Mar2019 | -8.74 % | - |
WOCKHARDT Earnings Per Share (EPS)
[BOM: 532300|NSE : WOCKPHARMA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-39 | Negative | |
Mar2022 | ₹-17 | Negative | |
Mar2021 | ₹62 | Positive | |
Mar2020 | ₹-6.25 | Negative | |
Mar2019 | ₹-18 | - |
WOCKHARDT Return on Capital Employed (ROCE)
[BOM: 532300|NSE : WOCKPHARMA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -5.88% | Negative | |
Mar2022 | -1.96% | Negative | |
Mar2021 | -5.5% | Negative | |
Mar2020 | -1.11% | Negative | |
Mar2019 | -2.87% | - |
WOCKHARDT Share Price vs Sensex
Current Share Price | : | ₹570.3 |
Current MarketCap | : | ₹ 8,747.6 Cr |
Updated EOD on | : | Apr 25,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -2.4% |
4.2% |
231.5% |
SENSEX | 1.3% |
2.6% |
24% |
WOCKHARDT related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
S&P BSE HEALTHCARE | -0.2% | 3.7% | 52.1% |
You may also like the below Video Courses
FAQ about WOCKHARDT Financials
How the annual revenues of WOCKHARDT have changed ?
The Revenues of WOCKHARDT have decreased by -17.93% YoY .
How the Earnings per Share (EPS) of WOCKHARDT have changed?
The Earnings Per Share (EPS) of WOCKHARDT has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs